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Abstract.  There is increasing demand for effective software process 
assessment and improvement in the medical device industry.  This is 
due to the expanding and complex role that software now plays in the 
operation and functionality of medical devices.   This paper outlines the 
development and current status of Medi SPICE a software process 
assessment and improvement model which is being developed to meet 
the specific requirements of this safety-critical domain.  This includes the 
selection of the most appropriate software process improvement model 
on which to base Medi SPICE.  Its initial development and restructuring 
to conform to ISO/IEC 15504-5:2012 and ISO/IEC 12207:2008.  The 
structure and content of its process reference model is outlined and an 
industry based trial assessment of 11 of its processes discussed.  
Current and future work is considered including the timeframe for the 
release of a full version of the Medi SPICE model.  
Keywords: Medical Device Software, Software Process Improvement, 
SPI, ISO/IEC 15504-5:2012, SPICE. ISO/IEC12207:2008, IEC 
62304:2006. 
1   Introduction 
Medical device development is a highly regulated industry and the level of 
rigor required is determined by the potential hazard/risk the device may pose 
to patients, healthcare professionals and third parties [1].  Initially medical 
devices were composed of hardware, or had very limited software content.    
Over recent years this has changed and the role and importance that software 
plays has continued to increase [2].  In many situations this has necessitated  
the development and inclusion of increasingly large software components 
which facilitate the operation and increased functionality that medical devices 
now provide [3].   In these circumstances it is not surprising that the size, 
scope and complexity of medical device software has substantially increased 
[4].      
The important role that software now plays in medical devices has been 
recognized by the European Union (EU).  This is  reflected  in the  latest 
amendment to the Medical Device Directive (MDD) (2007/47/EC) [5] which 
states standalone software may now be classified as an active medical device 
  
in its own right.  This is a significant development and in January 2012 the 
European Commission released a guidance document  for the qualification 
and classification of standalone medical device  software  MEDDEV 2.1/ [6] to 
provide additional clarity on this important  change.   
The Food and Drug Administration (FDA) who are responsible for the 
regulation and approval of medical devices in the United Sates (US) have also 
recognized the increasingly important role that software plays in this domain.  
As a consequence they have published a number of software specific 
guidance documents for medical device software development over the last 
number of years.  To remain up to date with current trends the  FDA have 
recently published the Medical Device Data Systems Final Rule [7]  and Draft 
Guidance for Industry and Food and Drug Administration Staff -  Mobile  
Medical Applications [8].   
Given the potential safety-critical nature of medical device software it must 
be developed  in compliance with the relevant regulations and recommended 
international standards of the geographical location where the medical device 
is to be marketed to receive regulatory approval  [9]. In order to market a 
medical device in the EU the receipt of the CE mark is essential and in the US 
FDA approval is required. In Australia, registration and approval is provided 
by the Therapeutic Goods Administration (TGA) and in Canada, by Health 
Canada.  These and similar approval bodies in other countries recommend 
conformance to a number of international standards and technical reports to 
help achieve compliance with national regulatory requirements.  These  
include IEC 62304:2006 [10],  ISO 14971:2007 [11], ISO 13485:2003 [12], EN 
60601-4:2000 [13],  IEC/TR 80002-1:2009 [14] , IEC 62366:2007 [15], IEC/TR 
61508:2005 [16], and IEC 60812:2006 [17].  
The level of regulatory compliance required is determined by the relevant 
regulatory body from a predefined classification scheme based on the 
potential risk/hazard posed by the medical device.   This is typified by the FDA 
who have 3 levels of concern and the EU who have 4 classes based on 
perceived potential hazard, ranging from low risk to high risk. A Medical 
device is evaluated against the relevant scheme and a classification is 
determined.  Based on this evaluation the organization developing the device 
is required to establish design controls in line with the medical device’s 
classification level. The higher the classification of the device, the more 
stringent the design controls and constraints that must be complied with [18].   
While regulatory bodies provide classification schemes, regulations, lists of 
approved or harmonized standards, technical reports and in some cases 
guidance documents the information is high-level and specific methods for 
performing the essential activities required have not been provided [19].  In 
these circumstances it is not surprising that medical device organizations 
producing software are compliance centric in their approach to its 
development.  This has been compounded by the fact that a domain specific 
software process assessment and improvement model which addresses the 
specific requirements of the highly regulated medical device software industry 
has not been available. It is therefore not surprising that there has been very 
  
limited adoption of software process improvement in the medical device 
industry [20].  
This did not pose such a serious problem in the past when the level of 
software in medical devices was small and the role it played had a limited 
impact on the overall operation of the device. As stated this has now changed 
and there is a specific requirement for highly effective and efficient software 
development processes to be in place [21].  In addition these processes need 
to be defined and adopted to facilitate the production of  the required 
deliverables in the correct manner in  order to achieve regulatory approval 
[18].   
To address this requirement the Regulated Software Research Group 
(RSRG) at Dundalk Institute of Technology (DkIT) is developing  Medi SPICE 
[22] a medical device domain specific software process assessment and 
improvement model.  The objective of Medi SPICE is to facilitate efficient 
medical device software process assessment and improvement by 
incorporating software engineering best practice coupled with the regulatory 
requirements of the medical device industry.   This work is taking place in 
association with members of the SPICE User Group, members of relevant 
international standard bodies and representatives from the medical device 
software industry. This collaborative process is a key aspect of  the 
development of Medi SPICE [23]. 
The remainder of this paper is structured as follows:  Sections 2 outlines 
the initial development of what subsequently became Medi SPICE.  Section 3 
presents the development of Medi SPICE which includes the initial processes 
which were developed and  the  restructuring of the model which took place 
as a result  of the release of ISO/IEC 12207:2008 [24] and ISO/IEC 15504-
5:2012 [25]. The definition of the Medi SPICE Process Reference Model 
(PRM) and a trial assessment of 11 of its Process Assessment Model (PAM) 
processes are also discussed in this section. Section 4 concludes the paper 
with a brief overview of the current status of Medi SPICE and the schedule for 
the full release of the model. 
2   The Initial Development of a Software Process 
Assessment and Improvement Model for the Medical Device 
Industry 
Having identified the initial requirement for process improvement in the area 
of medical device software development a number of preliminary studies were 
undertaken [26].  This work culminated in an extensive literature review being 
carried out which focused on the development of a domain specific software 
process assessment and improvement model for the medical device industry 
[18].  This incorporated analysis of software process improvement models 




)  [27] and 
ISO/IEC I5504-5:2006 [28].  While CMMI
® 
 and ISO/IEC I5504-5:2006  are 
effective and comprehensive models for general software development they 
  
do not address the specific requirements which are essential for regulated 
software development [29].  For other safety critical industries this has 
resulted in the development and deployment of domain specific software 
process assessment and improvement models which includes Automotive 
SPICE [30] for the automotive industry and SPICE for SPACE [31].   
It was recognized a similar approach was required for the medical device 
domain.  To initiate this key aspects of medical device software development 
were focused on and gap analysis undertaken. This included the areas of 
Configuration Management   and Software Risk Management.  This resulted 
in the development of a Configuration Management Capability Model (CMCM) 
[32] and a Risk Management Capability Model (RMCM) [33] both for use in 
the medical device software Industry. These models were based on CMMI
® 
and while they proved effective for the specific areas they addressed it was 
recognized that a more extensive approach was require. At this point a key 
question had to be considered which was should the CMMI
®
 or ISO/IEC 
I5504-5:2006 be used at the basis for the development of a comprehensive 
medical device software process assessment and improvement model?  The 
strengths of CMMI
®
 and ISO 15504-5:2006 were both identified and evaluated 
in the context of the requirements of medical device software development.  A 
key factor to emerge at this stage was the importance of IEC 62304:2006 
Medical device software—Software life cycle processes.    
2.1   IEC 62034:2006 
As the medical device industry added software to their products consideration 
had to be given as to how that software could be developed. Having 
considered the alternatives ISO/IEC 12207:1995 [34] was selected as the 
most appropriate standard to  implement for medical device software 
development.  As with the use of other standards in this domain the goal was 
to minimized risk and the possibility of medical device failure. While ISO/IEC 
12207:1995 was an effective standard it was developed for general software 
development and did not address the specific requirements of the medical 
device software industry [18].  This was highlighted by a review of the 
standard by the Association for the Advancement of Medical Instrumentation 
(AAMI) software committee.   This resulted in the decision to develop and 
implement a new domain specific  standard for medical device software 
development ANSI/AAMI SW68:2001 [35]. When this work was undertaken 
ISO/IEC 12207:1995 was used as the foundation on which ANSI/AAMI 
SW68:2001 was based.    
     ANSI/AAMI SW68:2001was revised and as a result a new standard IEC 
62304:2006 was developed and released.   The major differences between 
the two standards are that in IEC 62304:2006 three software safety classes 
are identified and a safety class is required to be assigned to each software 
system.  Based on the assigned safety class specific processes and tasks are 
required.  There is no longer a distinction made between primary and 
supporting processes and 2 processes were removed which had been part of 
  
ANSI/AAMI SW68:2001.  Some of the requirements from these processes 
were moved to other processes where relevant in IEC 62304:2006  [36].  
 IEC 62304:2006 provides coverage of the medical device software 
development processes.  As a result this standard plays a key role in the 
development and maintenance of medical device software and is harmonized 
with the European MDD and is approved by the FDA as a consensus 
standard.  IEC 62304:2006 is solely focused on software development and 
maintenance and does not address Requirements Elicitation and Validation 
which are considered system level processes.  For the development of medical 
device software based on IEC 62304:2006 it is required that a Quality 
Management System (QMS) is in place e.g.  ISO 13485:2003 [12]  and  a risk 
management process conformant with  ISO/IEC 14971:2007 [11]  is 
established.  
As IEC 62304:2006 was developed based on ANSI/AAMI SW68:2001 as 
stated the relationship with ISO/IEC 12207:1995 has been maintained.   This is 
highlighted in the standard as it states that its concepts and approach have 
been derived from  ISO/IEC 12207:1995 AMD 1:2002 [37] and AMD 2:2004 
[38] and have been tailored to the requirements for medical device software 
development.  The differences in IEC 62304:2006 are outlined in Annex C.6 
and they include:  
a) The standard excludes system level processes.   
b) Processes seen as duplicating activities which are documented 
elsewhere for medical devices are omitted.  
c) A safety risk management process and software release process 
have been added  
d) Documentation and verification are incorporated into the 
development and maintenance processes  
The key relationship between the IEC 62304:2006 and ISO/IEC 12207:1995 
AMD 1:2002 and AMD 2:2004 are also detailed at the process, task, and 
activity level in Table C.5 in Annex C.6. 
2.2 The Selection of the Software Process Assessment and 
Improvement Model on Which to Base the Model for the Medical Device 
Industry 
As a result of our preliminary studies and literature review the key relationship 
between IEC 62304:2006 and 12207:1995 AMD 1:2002 and AMD 2:2004 was 
defined and the level of its importance recognized as outlined in Section 2.1.  
While this was the case it was still important to evaluate CMMI
®
 and its 
relationship to IEC 62304:2006.   In 2009 the Software Engineering Institute 
published a white a paper “CMMI and Medical Device Engineering” [39]  
which presents a high-level description of how the CMMI
®
  does not provide 
adequate  coverage for medical device software developments  with  
particular reference to IEC 62304:2006 [18].   The objective of the white paper 
was to help facilitate the extension of CMMI
®
 to address this, but it also 
highlighted the considerable level of restructuring that would be required and 
the paper only considered this at a high level.  
  
     In contrast ISO/IEC 15504-5:2006 had been developed based on the PRM 
outlined in ISO/IEC 12207:1995 AMD 1:2002 and AMD 2:2004.  As a result of 
our detailed analysis of both ISO/IEC 15504-5:2006 and IEC 62304:2006 it 
was clear there was direct relevance, and synergy between these standards.  
This was due to their common foundation, both being based on ISO/IEC 
12207:1995 AMD 1:2002 and AMD 2:2004.  In addition Automotive SPICE 
had been successfully developed and implemented [40] and it addressed a 
mission critical domain not dissimilar to Medical device software development.  
Having evaluated and analyzed the alternatives the decision was taken to 
base the development of the medical device software process assessment 
and improvement model on ISO/IEC 15504-5:2006.  The title Medi SPICE 
was selected for the model to reflect this decision [22].  While it was 
recognized that where relevant ISO/IEC 15504-5:2006 would have to be 
amended and extended to meet the specific requirements of the medical 
device domain.   
3   The Development of Medi SPICE 
Having identified the specific requirements which  needed to be addressed  
and  having selected an overall  structure and strategy  the development of 
Medi SPICE commenced [19].  An initial task was the formal identification of 
the overall objectives of undertaking a Medi SPICE assessment.  These were 
defined as to determine the state of a medical device organization’s software 
processes and practices in relation to best practice and the regulatory 
requirements of the industry. The goal of such an assessment should be the 
identification of areas where process improvement can take place and to 
facilitate such improvement.  It was also recognized that Medi SPICE should 
be capable of being utilized as part of a process to select software suppliers 
when an organization wishes to offshore or outsource part or all of their 
medical device software development.  In this context Medi SPICE should be 
able to be used to evaluate the software process capability of third party or 
remote divisions and thereby provide key input into the selection process [41].  
Work then commenced on the development of a preliminary Medi SPICE 
PRM.  The initial focus was on the software engineering processes and some 
supporting processes. This preliminary PRM contained 11 processes: 
 Software Requirements Elicitation  
 System Architectural design  
 System Requirements Analysis  
 Software Requirements Analysis  
 Software Construction  
 Software Integration  
 Software Testing 
 Configuration Management 
 Change Request Management  
 Software Verification 
  
 Software Validation 
These processes were based on the structure of ISO/IEC 15504-5:2006, 
ISO/IEC 12207:1995 AMD 1:2002 and AMD 2:2004 and where relevant IEC 
62034:2006.  The outcomes defined incorporated best software engineering 
practice and the regulatory requirements of the medical device software 
domain. On completion, these processes were released for review by 
members of the SPICE User Group, international standards experts and 
representatives from the medical device software industry.  Based on their 
feedback the processes were further updated and amended.  
A key aspect of the development of Medi SPICE is the desire to ensure the 
model conforms to the latest revisions and additions to the medical device 
regulations, relevant international standards, technical reports and guidance 
documents.   It soon became apparent with the release of ISO/IEC 
12207:2008 that this would have a direct impact on the development of Medi 
SPICE.     
3.1 The Release of ISO/IEC 12207:2008   
The structure of ISO/IEC 12207:2008 is substantially different to that of 
ISO/IEC 12207:1995 AMD 1:2002 and AMD 2:2004.  This is reflected in the 
name of ISO/IEC 12207:2008 Systems and software engineering - Software 
life cycle processes which highlights that the standard has been extensively 
revised. This took place in tandem with the revision of  ISO/IEC 15288:2002 
[42].  As a result it no longer just addresses the requirements of the software 
engineering life cycle processes it now also addresses the system 
engineering processes as well.  This development has impacted on the 
revision of standards which have been derived from ISO/IEC 12207:1995 
AMD 1:2002 and AMD 2:2004.  In this context of particular relevance to Medi 
SPICE was the release of ISO/IEC 15504-5:2012 and the current revision of 
IEC 62034. ISO/IEC 15504-5:2012 now conforms to the structure of ISO/IEC 
12207:2008.  As part of the current revision of IEC 62034 to facilitate its next 
release a mapping was required to be undertaken between the processes of 
IEC 62034:2006 and ISO/IEC 12207:2008. 
A member of the RSRG is also a member of the IEC SC62A JWG3 
Standards Working Group (the IEC 62304 development team) and the RSRG 
were invited to contribute to this mapping.  To facilitate this it was important to 
analyze in detail the relationship between IEC 62034:2006 and ISO/IEC 
12207:1995 AMD 1:2002 and AMD 2:2004 which is documented in Table C.5 
of the current version of the standard. A member of the RSRG prepared an 
extended version of this table to include the complete details of the ISO/IEC 
12207:1995 AMD 1:2002 and AMD 2:2004 activities and tasks on which those 
of IEC 62304:2006 are based.  As a result of analyzing this information and 
comparing it with ISO/IEC 12207:2008 a direct mapping was made.   
Due to the restructuring that took place in ISO/IEC 12207:2008 the names 
and locations of a number of relevant processes, activities and tasks changed 
from the previous release of the standard.  As a result of further analysis it 
  
became clear that at the task level very minor adjustments had been made 
i.e. the term “developer” had been changed to “implementer” and notes have 
been added to some tasks.  The only exception was the ISO/IEC 12207:1995 
AMD 1:2002 and AMD 2:2004 task 6.4.2.2 Process Verification which had 
been removed from ISO/IEC 12207:2008.  This is important as it is utilized in 
IEC 62304:2006 as the basis for the Verify Integration Tests Procedures task.   
Details of this analysis and mapping were documented and provided to the 
IEC SC62A JWG3 Standards Working Group to assist with the definition of 
the relationship between the next release of IEC 62304 and ISO/IEC 
12207:2008.  
3.1 The Development of the Structure of the Medi SPICE PRM   
The selection of the appropriate processes for inclusion in the Medi SPICE 
PRM was a key activity.  The objectives of this were twofold: one was the 
selection of effective life cycle processes which would facilitate medical device 
software development.  The second was to facilitate conformance to the 
relevant medical device regulations, standards and guidance documents.  To 
achieve this, a prepublication version of ISO/IEC 15504-5:2012, IEC 
62304:2006 and ISO/IEC 12207:2008 were analyzed in detail. The analysis 
outlined in Section 3.1 on the mapping between IEC 62304:2006 and ISO/IEC 
12207:2008 was of particular value in this context.  This work was undertaken 
in tandem with an analysis of the relevant medical device regulations, 
standards, technical reports and guidance documents.  In this context 
particular reference was made to ISO 13485:2003 and ISO 14971:2007.  
Based on this analysis the structure of the Medi SPICE PRM was defined as 
consisting of a system life cycle processes category with 4 process groups 
and a software life cycle processes category with 3 process groups.  Initially 
42 processes and 15 subprocesses were identified. This included a medical 
device specific Software Risk Management process which was not part of 
ISO/IEC 15504-5:2012 or ISO/IEC 12207:2008. The addition of this process 
was necessitated by the requirements for medical device software 
development as outlined by IEC 62304:2006 and ISO 14971:2007.   The 
proposed structure of the Medi SPICE PRM was sent for review by members 
of the SPICE User Group, international standards experts and representatives 
of the medical device software industry.  Based on their feedback the number 
of processes was increased to 44 with the addition of the Software 
Development Planning and Software Release processes.   As a result the 
Medi SPICE PRM was structured as follows: 
System Life Cycle Processes Category  
 3 Agreement Processes and 7 Subprocesses; 
 6 Organizational Project - Enabling Processes and 6 Subprocesses; 
 7 Project Processes; 
 6 Organizational Project - Enabling Processes and 6 Subprocesses; 
 10 Technical Processes and 2 Subprocesses.  
   
  
Software Life Cycle Processes Category  
 8 Software Implementation Processes;  
 9 Software Support Processes  (including Software Risk 
Management); 
 1 Supplementary Process.                            
3.2 The Development of the Initial Medi SPICE PRM & PAM Processes 
Having defined the structure of the Medi SPICE PRM work began on the 
development of the PRM processes.  It was decided to initially focus on the 13 
processes which had a particular relevance to IEC 62034:2006. These 
processes are: 
 Software Development Planning; 
 Software Requirements Analysis; 
 Software Architectural Design; 
 Software Detailed Design; 
 Software Construction; 
 Software Integration; 
 Software Qualification Testing;  
 Software Release;   
 Software Maintenance; 
 Software Risk Management; 
 Software Configuration Management; 
 Software Change Request Management; 
 Software Problem Resolution. 
In line with  ISO/IEC 15504-2:2003 [43] for each of these processes an ID, a 
process name and a  process purpose was defined.  Based on the process 
purpose outcomes were identified which incorporated best practice and the 
medical device software regulatory requirements.   In this context the source 
of each outcome was recorded and where relevant each received an IEC 
62304:2006 safety classification.  The work carried out on the development of 
the preliminary PRM processes (outlined in Section 3) was of value when 
undertaking this task.   On completion these PRM processes were sent for 
review by members of the SPICE User Group, international standards experts 
which included members of the IEC SC62A JWG3 Standards Working Group 
and representatives from the medical device software industry.  
 As a result of the positive feedback received from the reviewers it was 
decided to develop PAM processes for the 13 PRM processes in 
conformance with ISO/IEC 15504-2:2003. It was realized that this could 
facilitate an industry based trial assessment to take place of these processes.  
In this context the RSRG had been approached by a European based medical 
device company “Medical Incorporated” (a synonym) with the request that 
such a trial assessment of some of their software development processes 
should be undertaken. The 13 PAM processes were developed which 
involved the identification of the specific practices which facilitate the 
  
achievement of the relevant process outcomes.  The sources of the specific 
practices were annotated with reference to best practice and the medical 
device software regulatory requirements.  Where relevant an IEC 62304:2006 
safety classification was recorded for specific practices.   For each process 
relevant input and output work products were also identified and recorded.  
These PAM processes were then reviewed by members of the SPICE User 
Group, international standards experts and representatives from the medical 
device software industry.  
3.3 The Industry based Medi SPICE trial Assessment  
Having received favorable feedback from the reviewers of the PAM 
processes, plans for undertaking the industry based Medi SPICE trial 
assessment commenced.  The need for a qualified ISO/IEC 15504 assessor 
to undertake the assessment was recognized. Given the imbedded nature of 
the majority of medical device software and specifically of the software being 
assessed for Medical Incorporated the selection of an Automotive SPICE lead 
assessor was identified as appropriate. While this was the case it was also 
recognized that training would have to be provided to address the specific 
requirements of the medical device software domain. In consultation with the 
company 3 Automotive SPICE Assessors agreed to undertake the training 
and the assessment.  They were a Lead Assessor, an Assessor and a 
Provisional Assessor.  Having reviewed the PAM processes and based on the 
requirements of the company it was decided for the trial 12 of the 13 
processes would be assessed and the Software Maintenance process was 
excluded. 
A date for the assessment was agreed and the Assessors undertook the 
medical device domain specific training provided by the RSRG and reviewed 
the PAM processes in detail.  It was also agreed that a member of the RSRG 
would participate in the assessment as a medical device software Technical 
Expert and provide support to the Assessors as and when required.   The 
assessment took place over a 5 day period. Having commenced it was 
decided that 11 rather than 12 processes would be assessed as the project 
under review had not reached the Software Qualification Testing stage.  The 
assessment was successfully undertaken and 8 processes were assessed as 
largely achieved at level 1 and 3 fully achieved.  The results of the 
assessment were presented and discussed with the company. Based on the 
assessment results specific guidance was provided to Medical Incorporated to 
facilitate process improvement which was presented in the full findings report.   
As this was a trial assessment it was important that the effectiveness of the 
Medi SPICE PAM processes were evaluated.  To this end after the 
assessment the 3 Assessors were interviewed and they provided positive 
feedback on the content of the Medi SPICE PAM processes.   With regard to 
the medical device domain training for the Assessors two issues were 
identified that required attention.  These were the use of Software Of 
Unknown Provenance (SOUP) and the handling of residual risk.   While these 
  
had been discussed as part of the training it emerged during the assessment 
that the Assessors were confused about them with respect to medical device 
software development.  These issues were clarified by the RSRG medical 
device software Technical Expert when they arose. These were discussed 
with the Assessors and it was important to ensure both of these topics were 
properly addressed as part of any future Assessor training program. 
It was also important to evaluate the relevance and effectiveness of the 
Medi SPICE PRM processes and the assessment to the organization.  To this 
end the Senior Technical Manager, Software Quality Manager, and a Senior 
Software Engineer who had all participated in the assessment were 
interviewed.  Each highlighted the relevance of the focus placed on specific 
aspects of the processes being assessed.  When required the assessment 
team’s ability to explain what and why specific information was being 
requested was considered of value. Of particular importance was the final 
report which they considered presented a realistic assessment of their 
processes. The recommendations for improvement were recognized as 
relevant and of value and a process improvement program is planned based 
on the assessment findings. While it was clearly stated and recognized this 
was a trial assessment all aspects of the assessment and its outcomes were 
very positively received by Medical Incorporated.  
4   Current Status and Future Plans 
The development of the remaining Medi SPICE PRM processes is currently 
under way.  The number of RSRG team members working on the 
development of Medi SPICE has recently been increased and it is now 
planned to release a draft version of the full Medi SPICE PRM by May 2013.   
It is also planned this will be followed by the release of the draft version of the 
full Medi SPICE PAM by September 2013.  It is anticipated that a full release 
of the  Medi SPICE model will take place in December 2013.   
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